Use of Somanetics’ INVOS Cerebral Oximeter Significantly Decreased Stroke Rate and Adverse Clinical Outcomes
Somanetics Corporation (Nasdaq: SMTS, news) today announced that the results of the first randomized, prospective and blinded study using the Company’s INVOS® […]
3 min read